Clinical Trial Update: Rarecells Molecular Biomarkers for Early Detection of Lung Cancer

View source ↗

Summary

A clinical trial update indicates Rarecells Diagnostics SAS is recruiting for a study on molecular biomarkers for early detection of lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Rarecells Diagnostics SAS | Conditions: Lung Cancer, Pulmonary Neoplasm | Status: RECRUITING